Hyperinsulinemia predicts coronary heart disease risk in healthy middle- aged men: The 22-year follow-up results of the Helsinki Policemen Study

Circulation

Volumn 98, Issue 5, 1998, Pages 398-404

  Pyörälä, Marja ^a   Miettinen, Heikki ^a   Laakso, Markku ^a   Pyörälä, Kalevi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coronary disease; Epidemiology; Insulin; Risk factors

Indexed keywords

ADULT; ARTICLE; CORONARY RISK; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; ORAL GLUCOSE TOLERANCE TEST; POLICE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0345698971     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.5.398     Document Type: Article

References (48)

1. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care. 1990; 13:631-654.
2. Jarrett RJ. Why is insulin not a risk factor for coronary heart disease? Diabetologia. 1994;37:945-947.
3. Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia. 1994;37:953-955.
4. Savage PJ, Saad MF. Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J. 1993;69:473-475.
5. Stem MP. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia. 1994;37:956-958.
6. Wingard D, Barrett-Connor E, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care. 1995;18:1299-1304.
7. McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care. 1995; 18:1294-1298.
8. Pyörälä K. Relationship of glucose tolerance and plasma insulin to incidence of coronary heart disease: results from two population studies from Finland. Diabetes Care. 1979;2:131-141.
9. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
10. Ducimetière P, Eschwège E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
11. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand. 1985;701(suppl):38-52.
12. Eschwège E, Richard JL, Thibult N, Ducimetière P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. Horm Metab Res. 1985;15:41-46.
13. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:356-361.
14. Møller LF, Jespersen J. Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk. 1995; 2:235-240.
15. Welborn TA, Knuiman MW, Ward N, Whittall DE. Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Pract. 1994;26:51-59.
16. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:835-837.
17. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM. Serum insulin and incident coronary heart disease in middle-aged men. Am J Epidemiol. 1996;144:224-234.
18. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
19. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Ekfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997;20:935-942.
20. Yarnell JWG, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J. 1994;71: 293-296.
21. Lakka TA, Lakka HM, Salonen JT. Hyperinsulinemia and the risk of coronary heart disease. N Engl J Med. 1996;335:976-977. Letter.
22. Welin L, Eriksson H, Larsson B, Ohlson LO, Svärdsudd K, Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men. Diabetologia. 1992;35:766-770.
23. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersma RA. Glucose tolerance, plasma insulin, HDL-cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61-69.
24. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994;4:40-45.
25. Rewers M, Shetterly SM, Baxter J, Hamman RF. Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): the San Luis Valley Diabetes Study. Circulation. 1992;85:865. Abstract.
26. Liu QZ, Knowler WC, Nelson RG, Saad MF, Charles MA, Liebow IM, Bennett PH, Petitt DJ. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians: cross-sectional and prospective analyses. Diabetes. 1992;41:1141-1150.
27. Tuomilehto J, Tamosiunas A, Dowse G, Gareeboo H, Fareed D, Alberti KGMM, Zimmet P, for the Mauritius NCD Group. Hyperinsulinemia does not explain the high risk of cardiovascular disease (CVD) in Mauritius. Diabetotogia. 1996;39(suppl 1):A68 Abstract.
28. Godsland IF, Bruce R, Leyva F, Worthigton M, Wallon C, Stevenson JC. Insulin and high-density lipoprotein as predictors of coronary heart disease incidence during 11.3 years of follow-up. Ear Heart J. 1996; 17(suppl):38. Abstract.
29. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol. 1994;140:857-869.
30. Lindberg O, Tilvis RS, Strandberg TE, Valvanne J, Sairanen S, Ehnholm C, Tuomilehto J. Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc. 1997;45:407-412.
31. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
32. Laakso M, Sarlund H, Salonen R, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
33. Agewall S, Fagerberg B, Attwall S, Wendelhag I, Urbanovicius V, Wikstrand A. Carotid artery wall thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
34. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809-1817.
35. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
36. Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: Helsinki Policemen Study. J Chronic Dis. 1979;32:729-745.
37. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645-658.
38. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1968.
39. Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. Circulation. 1968;38:1104-1115.
40. Åstrand PO, Ryhming I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol. 1954;7:218-221.
41. Hyvärinen A, Nikkilä E. Specific determination of blood glucose with o-toluidine. Clin Chim Acta. 1962;7:140-143.
42. Herbert V, Lau KS, Gotlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol. 1965;25:1375-1384.
43. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195:357-366.
44. Björkstén F. Determination of plasma and serum triglycerides with a fully automated method. Clin Chim Acta. 1972;40:143-152.
45. Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series No. 727.
46. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.
47. Mohamed-Ali V, Gould MM, Gillies S, Goubet S, Yudkin JS, Haines AP. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects: evidence against a modulating role for insulin. Diabetologia. 1995;38:1110-1116.
48. Haffner SM. Cardiovascular risk factors and the prediabetic syndrome. Ann Med. 1996;28:363-370.